HROW – harrow, inc. (US:NASDAQ)
Stock Stats
News
Harrow Expands VEVYE® Access for All Program to ImprimisRx's Klarity-C Patients [Yahoo! Finance]
Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
Harrow, Inc. (NASDAQ: HROW) had its price target lowered by analysts at B. Riley from $69.00 to $65.00. They now have a "buy" rating on the stock.
Harrow, Inc. (NASDAQ: HROW) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results [Yahoo! Finance]
Form 4 HARROW, INC. For: Apr 03 Filed by: BOLL ANDREW R.
Form SCHEDULE 13D/A HARROW, INC. Filed by: BAUM MARK L
Form 4 HARROW, INC. For: Apr 03 Filed by: SAHAREK JOHN P.
Form 4 HARROW, INC. For: Apr 03 Filed by: BAUM MARK L
Form 10-K HARROW, INC. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.